Methoxyphenyl Imidazolines as Potential Activators of p53

The use of p53-MDM2/X inhibitors is a prospective strategy in anti-cancer therapy for tumors with wild type p53 protein. In our study, new low-molecular-weight inhibitors of the p53-mdm2 interaction have been proposed. The two-step synthesis of the imidazoline core with subsequent modifications for...

Full description

Bibliographic Details
Main Authors: Daniil R. Bazanov, Nikolay V. Pervushin, Natalia A. Lozinskaya, Gelina S. Kopeina
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Medical Sciences Forum
Subjects:
Online Access:https://www.mdpi.com/2673-9992/14/1/100
_version_ 1797609801220358144
author Daniil R. Bazanov
Nikolay V. Pervushin
Natalia A. Lozinskaya
Gelina S. Kopeina
author_facet Daniil R. Bazanov
Nikolay V. Pervushin
Natalia A. Lozinskaya
Gelina S. Kopeina
author_sort Daniil R. Bazanov
collection DOAJ
description The use of p53-MDM2/X inhibitors is a prospective strategy in anti-cancer therapy for tumors with wild type p53 protein. In our study, new low-molecular-weight inhibitors of the p53-mdm2 interaction have been proposed. The two-step synthesis of the imidazoline core with subsequent modifications for the nitrogen atom was carried out. New molecules caused the accumulation of p53 protein levels more than seven times than in comparison with the control. The accumulation of proapoptotic proteins such as p21 and PUMA has also been investigated, and the mechanism of cell death has been shown.
first_indexed 2024-03-11T06:06:30Z
format Article
id doaj.art-c1d371c3d969417dbd2c62111727d05a
institution Directory Open Access Journal
issn 2673-9992
language English
last_indexed 2024-03-11T06:06:30Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series Medical Sciences Forum
spelling doaj.art-c1d371c3d969417dbd2c62111727d05a2023-11-17T12:58:12ZengMDPI AGMedical Sciences Forum2673-99922022-11-0114110010.3390/ECMC2022-13494Methoxyphenyl Imidazolines as Potential Activators of p53Daniil R. Bazanov0Nikolay V. Pervushin1Natalia A. Lozinskaya2Gelina S. Kopeina3Department of Chemistry, M. V. Lomonosov Moscow State University, 119992 Moscow, RussiaDepartment of Medicine, M. V. Lomonosov Moscow State University, 119991 Moscow, RussiaDepartment of Chemistry, M. V. Lomonosov Moscow State University, 119992 Moscow, RussiaDepartment of Medicine, M. V. Lomonosov Moscow State University, 119991 Moscow, RussiaThe use of p53-MDM2/X inhibitors is a prospective strategy in anti-cancer therapy for tumors with wild type p53 protein. In our study, new low-molecular-weight inhibitors of the p53-mdm2 interaction have been proposed. The two-step synthesis of the imidazoline core with subsequent modifications for the nitrogen atom was carried out. New molecules caused the accumulation of p53 protein levels more than seven times than in comparison with the control. The accumulation of proapoptotic proteins such as p21 and PUMA has also been investigated, and the mechanism of cell death has been shown.https://www.mdpi.com/2673-9992/14/1/100p53nutlinmdm2mdmximidazoline
spellingShingle Daniil R. Bazanov
Nikolay V. Pervushin
Natalia A. Lozinskaya
Gelina S. Kopeina
Methoxyphenyl Imidazolines as Potential Activators of p53
Medical Sciences Forum
p53
nutlin
mdm2
mdmx
imidazoline
title Methoxyphenyl Imidazolines as Potential Activators of p53
title_full Methoxyphenyl Imidazolines as Potential Activators of p53
title_fullStr Methoxyphenyl Imidazolines as Potential Activators of p53
title_full_unstemmed Methoxyphenyl Imidazolines as Potential Activators of p53
title_short Methoxyphenyl Imidazolines as Potential Activators of p53
title_sort methoxyphenyl imidazolines as potential activators of p53
topic p53
nutlin
mdm2
mdmx
imidazoline
url https://www.mdpi.com/2673-9992/14/1/100
work_keys_str_mv AT daniilrbazanov methoxyphenylimidazolinesaspotentialactivatorsofp53
AT nikolayvpervushin methoxyphenylimidazolinesaspotentialactivatorsofp53
AT nataliaalozinskaya methoxyphenylimidazolinesaspotentialactivatorsofp53
AT gelinaskopeina methoxyphenylimidazolinesaspotentialactivatorsofp53